Abingdon Health (LSE:ABDX) Stock Based Compensation : £0.03 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Stock Based Compensation?

Abingdon Health's Stock Based Compensation for the six months ended in Dec. 2023 was £0.01 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was £0.03 Mil.

Abingdon Health Stock Based Compensation Historical Data

The historical data trend for Abingdon Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Stock Based Compensation Chart

Abingdon Health Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Stock Based Compensation

Get a 7-Day Free Trial

0.03

0.04

1.37

0.23

0.03

Abingdon Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Stock Based Compensation	Get a 7-Day Free Trial					0.10	0.13	0.01	0.02	0.01

Abingdon Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.03 Mil.

Abingdon Health Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (LSE:ABDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines